Advanced search
Start date
Betweenand

Desferriosamine: albumin conjugates for the therapy of iron overload

Grant number: 17/16379-0
Support type:Scholarships in Brazil - Scientific Initiation
Effective date (Start): March 01, 2018
Effective date (End): December 31, 2018
Field of knowledge:Physical Sciences and Mathematics - Chemistry - Inorganic Chemistry
Principal researcher:Breno Pannia Esposito
Grantee:Lucas Antonio Arias Correia
Home Institution: Instituto de Química (IQ). Universidade de São Paulo (USP). São Paulo , SP, Brazil

Abstract

Chelators currently employed in iron overload therapy have important side effects. Desferrioxamine (DFO), the main agent of this therapy, presents rapid renal clearance, without oral activity, which requires from patients prolonged and almost daily infusions. In this project, we aim to couple DFO to bovine serum albumin (BSA) and / or ovalbumin (OVA) through amino acids with amine or carboxyl-containing side groups. The final objective is to obtain conjugates that present lower renal clearance and, therefore, lower need for prolonged infusions to the patient. (AU)

News published in Agência FAPESP Newsletter about the scholarship:
Articles published in other media outlets (0 total):
More itemsLess items
VEICULO: TITULO (DATA)
VEICULO: TITULO (DATA)

Scientific publications
(References retrieved automatically from Web of Science and SciELO through information on FAPESP grants and their corresponding numbers as mentioned in the publications by the authors)
CORREIA, LUCAS ANTONIO ARIAS; GARCIA, RODRIGO SANTOS; REAL, CAROLINE CRISTIANO; UZUELI, DANIEL HENRIQUE; SA, ULISSES LACERDA DE FIGUEIREDO; MARQUES, FABIO LUIZ NAVARRO; COLNAGO, LUIZ ALBERTO; ESPOSITO, BRENO PANNIA. Development of a platform for the production of multiple modal chelating and imaging agents using desferrioxamine and bovine albumin as a model. CHEMICAL PAPERS, v. 75, n. 3, p. 1157-1163, MAR 2021. Web of Science Citations: 0.

Please report errors in scientific publications list by writing to: cdi@fapesp.br.